Treatment of chronic low back pain with botulinum neurotoxins
- 126 Downloads
In a double-blind, randomized, placebo-controlled study, administration of botulinum toxin A (Botox; Allergan Inc., Irvine, CA) into paraspinal muscles using a novel technique produced significant pain relief in 60% of patients with chronic, refractory low back pain. A similar yield of 53% was noted in a prospective, randomized, open-label study of 75 patients, with 14 months of follow-up. In this study, an early response predicted later responsiveness, with 91% of the responders continuing to respond to repeat injections. The technique of treatment for both studies included covering the whole length of the lumbar erector spinae with one injection given at each lumbar level regardless of pain, tenderness, or trigger point location(s). The dose per injection site was 50 U (Botox), with the total dose per session not to exceed 500 U. Side effects were uncommon and consisted of a transient, mild flu-like reaction in 5% of the patients. Botulinum treatment of paraspinal muscles can reduce pain in a substantial number of patients with refractory chronic low back pain and is safe in the recommended doses.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Anderson GB, Pope MH, Fromyer JW, Snook SH: Epidemiology and cost. In Occupational Low Back Pain: Assessment, Treatment and Prevention. Edited by Pope MH, Anderson GB, Frymoyer JW, Chaffin DB. St. Louis: Mosby Yearbook; 1991:107–146.Google Scholar
- 3.Spengler AM, Bogos SA, Martin NA, et al.: Back injuries in industry. Overview and cost analysis. Spine 1986, 11241–11245.Google Scholar
- 7.Battie MC, Videman T, Levalahati E, et al.: Heritability of low back pain and the role of disc degeneration. Pain 2007, In Press.Google Scholar
- 8.Gray’s Anatomy. Edited by Bannister LH et al. Edinborough: Churchill Livingston; 1995.Google Scholar
- 20.Fillipi GM, Errico P, Santarelli R, et al.: Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993, 113:400–404.Google Scholar
- 28.Lang AM: A pilot study of botulinum toxin type A (BOTOX), administered using novel injection technique for treatment of myofascial pain. Am J Pain Manage 2000, 10:108–112.Google Scholar
- 29.Royal MA, Guneya I, Bhakta B, et al.: Botulinum toxin type A in the treatment of refractory myofascial pain. Neurology 2001, 56(Suppl 3):A350.Google Scholar
- 30.Cannard K, Difazio M, Jabbari B: The efficacy of botulinum toxin A for treatment of low back pain caused by trauma and strain injury [abstract]. Neurology 2005, 64(Suppl):151.Google Scholar